These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4035225)

  • 1. [Hemorheological changes induced by uremia. Effects of hemodialysis].
    Delsignore R; David S; Francia MT; Bottazzi G; Crotti G
    Ric Clin Lab; 1985; 15 Suppl 1():335-45. PubMed ID: 4035225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorheological changes in retinal vein occlusions].
    Peduzzi M; Debbia A; Guerrieri F; Zirilli E; Bolzani R; Barbieri U
    Ric Clin Lab; 1985; 15 Suppl 1():321-6. PubMed ID: 4035223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hemodialysis, using acetate and bicarbonate, on erythrocyte deformability].
    Novák Z; Búzás E; Salgó L; Gál G
    Orv Hetil; 1991 Sep; 132(38):2083-6. PubMed ID: 1923480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis.
    Martínez M; Vayá A; Alvariño J; Barberá JL; Ramos D; López A; Aznar J
    Clin Hemorheol Microcirc; 1999; 21(1):1-6. PubMed ID: 10517483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheology and acute in vivo changes in non-viscous serum factors].
    Cortinovis A; Crippa A; Sciacca V; Caravaggio V
    Minerva Med; 1988 May; 79(5):355-66. PubMed ID: 3374827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of hemorheological parameters within the framework of chronic brain disease].
    Pernigotti L; Neirotti M; Cappa G; Musso M; Fabris F
    Ric Clin Lab; 1985; 15 Suppl 1():307-12. PubMed ID: 4035220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorheological mechanisms in Alzheimer's disease.
    Chang CY; Liang HJ; Chow SY; Chen SM; Liu DZ
    Microcirculation; 2007 Aug; 14(6):627-34. PubMed ID: 17710633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodialysis of uremic patients with a high risk of bleeding].
    Qu SL; Chen QG
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):131-3, 10. PubMed ID: 2776054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemorheological changes during exercise].
    Signorelli S; Tornetta D; Ferrara M; Interlandi S; Lo Duca S; Monaco S; Cottini E; Andreozzi GM
    Ric Clin Lab; 1985; 15 Suppl 1():163-7. PubMed ID: 4035211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M; Graziani G; Tenconi PM; Martinelli I; Ponticelli C
    Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cholesterol levels on hemorheological parameters in diabetic patients.
    Ercan M; Konukoğlu D; Erdem T; Onen S
    Clin Hemorheol Microcirc; 2002; 26(4):257-63. PubMed ID: 12122231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index].
    Achilli E; Cortinovis A; Ardemagni P; Crippa A
    Minerva Cardioangiol; 1999 Apr; 47(4):95-119. PubMed ID: 10416313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders.
    Kowal P; Zmyślony A
    Clin Hemorheol Microcirc; 2008; 40(3):229-34. PubMed ID: 19029646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
    Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.